Citalopram and escitalopram in older adults and associated QTc prolongation: a clinical audit
Background: Citalopram and escitalopram are commonly used serotonin-specific reuptake inhibitors (SSRIs) for the treatment of depression and anxiety; which are known to cause corrected QT interval (QTc) prolongation.
Prasanna, Aparna, Kar, Shreyan
core
Evaluating <i>Caenorhabditis elegans</i> as a Toxicity Model for Reuptake Inhibitors. [PDF]
Hernandez CE, Van Stone A, So C.
europepmc +1 more source
Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression
Background To investigate the association between pre-trial expectancy, suggestibility, and response to treatment in a trial of escitalopram and investigational drug, COMP360, psilocybin, in the treatment of major depressive disorder (ClinicalTrials.gov ...
David Erritzoe (5196923) +5 more
core
Association between body mass index and serum concentrations of olanzapine and selective serotonin reuptake inhibitors in patients with eating disorders. [PDF]
Hersleth V +6 more
europepmc +1 more source
Association Between <i>CYP450</i> Polymorphisms and Treatment Outcomes of Escitalopram and Venlafaxine in Patients with Post Stroke Depression. [PDF]
Wang Y +6 more
europepmc +1 more source
Use of Corrected QT Cutoffs Derived from Biological Variation to Predict Adverse Events Due to Antipsychotic Drugs: Case Report. [PDF]
Wu AHB, Alamillo M, Kendrick K.
europepmc +1 more source
Lascufloxacin-Induced QT Prolongation in an Elderly Patient Treated With Escitalopram: A Case Report. [PDF]
Koide T +4 more
europepmc +1 more source
Retraction: Metoprolol, N-Acetylcysteine, and Escitalopram Prevents Chronic Unpredictable Mild Stress-Induced Depression by Inhibition of Endoplasmic Reticulum Stress. [PDF]
Frontiers Editorial Office.
europepmc +1 more source

